Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 13 Aug 2022 |
2 | Reply to Exam Report (MIS-R) | 23 Feb 2023 |
3 | TM-O(NOTICE OF OPPOSITION) | 24 Apr 2024 |
4 | Journal Copy | 26 Apr 2024 |
5 | Annexure -1 under rule 46 | 18 Oct 2024 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 18 Oct 2024 |
7 | Annexure -1 under rule 46 | 18 Oct 2024 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 18 Oct 2024 |
1 | EXAMINATION REPORT | 14721097 | 31 Jan 2023 | |
2 | Hearing Notice (Show Cause) | 15692675 | 25 Jul 2023 | |
3 | Hearing Notice (Show Cause) | 16145004 | 29 Sep 2023 | |
4 | Tribunal Accepted Notice for : 5568266 | 16973714 | 6422380 | 29 Dec 2023 |
5 | Opposition Notice | 18062859 | 6713358 | 29 Apr 2024 |
6 | Opposition Counter Statement | 18391480 | 6783601 | 26 Jun 2024 |
Trademark was applied on 13 August 2022 with IP India.
Proprietor of Mvaxin is BHARAT BIOTECH INTERNATIONAL.
Class(es) in which the trademark was applied to is 5.
Status of Mvaxin is Opposed.
Application number alloted to the trademark is 5568266.
Vatsala Singh Hasan is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD